What's Fair in Device Write-Offs
Executive Summary
In recent months, the SEC has cracked down on technology companies that have attributed the bulk of their acquisition costs to IPR&D (in process research and development) write-offs so that it does not inflate future earnings. Now there are signals from the SEC that it is preparing to crack down on the share of acquisition costs, and medical product companies, particulary device firms, could be hit.